# Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients

> **NCT03895437** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Tolerion, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** TOL-3021
- **OTHER:** TOL-3021 Placebo

## Key facts

- **NCT ID:** NCT03895437
- **Lead sponsor:** Tolerion, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-17
- **Primary completion:** 2021-03-15
- **Final completion:** 2023-09-30
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03895437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03895437, "Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03895437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*